Killing Cancer: Meet This Innovative Biotech Player

Sign up for this week’s All Access giveaway here

Marc Hedrick MD, President and CEO of Plus Therapeutics, Inc PSTV, was a guest on Benzinga’s All Access on October 14, 2022.

Plus Therapeutics is developing targeted radiotherapeutics, a novel treatment for cancer. The technology delivers massive amounts of radiation to the tumor, without damaging the healthy cells surrounding the cancer.

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechPenny StocksInterviewGeneralBenzinga All AccessPartner ContentPlus Therapeutics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!